Governor Cuomo Announces He Will Visit States That Have Legalized Cannabis Programs to Help Inform His Efforts to Pass Legislation as Part of Budget

Builds on Regional Cannabis Regulation and Vaping Initiatives Previously Announced With Connecticut, New Jersey, Pennsylvania, Rhode Island and Massachusetts

Governor Cuomo: “I’m going to visit Massachusetts, Illinois and California or Colorado, which are three states that have legalized it and have different versions, and bring my team to meet with them, discuss what they’ve done, what’s worked, what hasn’t worked.”

Screenshot 2020-02-25 09.14.01NEW YORK: Governor Andrew M. Cuomo announced that he will visit states that have legalized cannabis programs to learn more about their programs to help inform his efforts to pass similar legislation in the state budget this year. This builds on the regional cannabis regulation and vaping initiatives previously announced with Connecticut, New Jersey, Pennsylvania, Rhode Island and Massachusetts to establish a set of core principles on issues related to market regulation and empowerment; public health; public safety and enforcement; and vaping best practices.

VIDEO of the Governor’s announcement is available on YouTube here and in TV quality (h.264, mp4) format here.

AUDIO is available here.

A rush transcript of the Governor’s remarks are available below:

Governor Cuomo: One other point on marijuana, which is another issue that is in this budget. I said yesterday it is a major priority. I also want to make sure that it is done correctly, and you look at states that have legalized marijuana, many of them have generated more questions. One of those issues that everybody has goals, we want a goal of social equity, we want to make sure young people can’t get it, et cetera. We want to make sure there are advantages to communities that have been oppressed. But, then you look at the aftermath and many of those goals haven’t been met, right?

So, I’m going to visit Massachusetts, Illinois and California or Colorado, which are three states that have legalized it and have different versions, and bring my team to meet with them, discuss what they’ve done, what’s worked, what hasn’t worked. Has the social equity piece worked? Has the law enforcement piece worked? So that we have the best bill and the best system when we pass it, and I want to pass it by April 1. […]

The conclusion is we want to coordinate our laws the best we can. In other words, you don’t want New York competing with New Jersey, you don’t want New York competing with Connecticut. You don’t want people driving to New Jersey, because they can get more in New Jersey, or a higher percentage in New Jersey, or they have a different age in New Jersey, or a lower tax rate. So, it’s regional coordination. But then if you look at what has happened in states that have done it, about 11 states have legalized marijuana. Everybody talks about the goals, we want a social equity component, we want to make sure it’s policed. They have all these goals, but many of the programs once they’ve been implemented and they went back and looked, they didn’t meet those goals.

You know, our political debate now is all about “I have a plan.” Yeah, everybody has a plan, but can you actually get it done and does it turn out the way you planned it, right? That’s the big question, and that’s where government usually gets into trouble. So, I want to make sure we learn from them. We have the regional coordination piece. We are the first state that has really been looking through that lens. I now literally want to go to California, Illinois, Massachusetts, sit with them, what was your plan, how did it work out, what did you learn, what can we incorporate.

Cresco Labs Announces Closing Of Acquisition In New York State

Acquisition Adds One of Only 10 Vertically Integrated Cannabis Business Licenses Issued by the State of New York

ILLINOIS: Cresco Labs, one of the largest vertically integrated multi-state cannabis operators in the United States, today announced that it has closed its acquisition of 100% of the membership interests of Gloucester Street Capital, the parent entity of Valley Agriceuticals, via a merger between Gloucester and a subsidiary of Cresco Labs. As a result of this acquisition, Cresco Labs now holds one of the 10 vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health. Each license gives the operator the right to operate one cultivation facility and four dispensaries in New York. The New York market is projected to grow to $500 million by 20221.

“New York is one of the most influential consumer markets in the world and we expect the state to act as a cornerstone in Cresco Labs’ plan to continue building the most strategic and valuable geographic footprint in the U.S. cannabis industry,” said Charles Bachtell, CEO and Co-founder of Cresco Labs. “Since recently receiving regulatory approval for this transaction, Valley Ag has opened two new dispensaries in Williamsburg, Brooklyn and Huntington, Long Island. As a result, Cresco Labs enters the New York market with four strategically located dispensaries. These assets position us well to immediately generate meaningful revenue from this market. As we fully implement the world-class branding, marketing and distribution expertise that has helped us to develop leading positions in some of the most attractive cannabis markets in the country, we expect to steadily increase our share of a market that is projected to grow to $500 million by 2022.”

“Cresco Labs has an incredible vision for the future of the cannabis industry, and they were the obvious choice to partner with based on their superior management team, focus on compliance and experience working across hyper-regulated industries,” said Gloucester Street Capital CEO Stephen Ashekian. “I believe their strategic decision making, commitment to social equity and priority for putting the patients first will make them a leader in the New York market.”

In addition to the new dispensaries in Williamsburg, Brooklyn and Huntington, Long Island, Cresco Labs also has operating dispensaries in Bardonia and New Hartford.

Currently a medical-use only market, New York has approximately 107,000 certified patients and 2,500 registered practitioners. The State’s medical cannabis program has 15 qualifying conditions including chronic pain, post-traumatic stress disorder (PTSD), and opioid replacement.

‘I Can Still Do That Foundation’ & Tom Pacheco Premiere “Freida’s Secret Garden”

Shot in Humboldt County, the video uses local talent and filmmakers to promote cannabis legalization

NEW YORK: The I Can Still Do That Foundation, a New York City-based non-profit whose mission is to connect people so they can share information and empower each generation to teach the others, launched “Freida’s Secret Garden “  a pro-pot music video based on a song by legendary Woodstock singer-songwriter Tom Pacheco.

“The time to end irrational prohibition of cannabis is now,’  Dan Schneider, Executive Director of the Foundation, announced. “With 33 States now recognizing the benefits of medical cannabis and another 11 States legalizing recreational cannabis, a majority of Americans are in favor of legalization and the end of the irrational and Draconian laws which have stifled research on the potential benefits of cannabis. These laws have had a disparate impact on people of color and restoration of civil rights to those who have been adversely affected is also required to promote equity. The patchwork of irrational and inconsistent federal and state laws must end and the federal law must allow these now legal business to access the federal banking system to that black market producers of questionable products can be replaced by healthy and tested, legal cannabis and CBD products.”

“We want to thank advisor Lelehnia DuBois and her friends in the Humboldt County for helping us make the new music video,” Schneider said. “You can see the new video here in a sneak peek. Please share it with friends. We are trying to help Tom get the recognition he deserves as a legendary singer/songwriter who has written songs for Bob Dylan, The Band, Jefferson Starship, and others. He has a music publishing catalogue of more than 500 songs; “Freida’s” is just one of many great ones.

Still Do That advisor, Curved Papers Founder Michael O’Malley, said, “This song and video bring together the West Coast and East Coast hippie vibes – from Humboldt County to Woodstock – that have given rise to the contemporary cannabis legalization movement. Call it Cannafest Destiny. The fun, the healing compassion and sensible restoration of marijuana’s rightful place in society are all captured humorously in Tom’s lyric and rocking rhythm.

David Rheins, founder of the Marijuana Business Association and Still Do That Advisor agreed: “Marijuana has gone mainstream, and the mainstream media is now getting hip to the power of the plant and the amazing possibilities that legalization brings.  Through the work of artists and activists like  Tom Pacheco,  we are raising cannabis consciousness, and dispelling the dangerous myths and harmful policies of prohibition.”

Still Do That Advisor Melissa Gibson, founder of Hemp and Humanity said, “This folksy and campy musical send-up to the authentic cannabis lifestyle pays homage to the plant, place and people who have championed it for generations. As marijuana use reaches a tipping point in mainstream acceptance, and the cannabis industry has attracted big business, Tom Pacheco take us back to the root(s) of this plant and its essential spirit of connecting humans with one another. What Frieda and her happy, hippy grandson Paul know, is that cannabis has the power to heal, clothe, feed, house, fuel and sustain human’s ability to live on this earth. And that’s worth singing about.”

Still Do That Advisor Lelehnia DuBois, cannabis community advocate and Sensi Magazine publisher, who co-produced the video and played the title role of Freida added, “I come from a culture of Frieda’s. It felt like she was my own mother. It was an honor to play the role”

According to Schneider, an entertainment lawyer by trade, the Foundation plans to produce a weekly TV news series called, “High Hopes”,  to educate people on the history, legal issues, health issues, science and finance surrounding the booming legal cannabis industry.  “We may even use Tom Pacheco’s song as a theme song for our TV series,” Schneider said. “We are currently looking for partners and sponsors for the series and are particularly interested in pro-cannabis celebrities to help demystify the stigma surrounding cannabis.”

Daytrip Expands CBD Sparkling Water Line To New York And New Jersey Markets

Daytrip to introduce THC sparkling water line by end of year

NEW YORK:  Daytrip, the leading cannabis lifestyle brand announced today its expansion into the New York and New Jersey area. After an initial launch in June 2019 across California, Washington, Oregon and Michigan, Daytrip is staking its claim in the metropolitan area as the premier CBD beverage.

Daytrip’s product line will now be available in several retailers across the metropolitan area including Fairway Market, Food Emporium, ShopRite, Westside Market and many others, available in four natural fruit flavors: Cherry, Coconut Pineapple, Lemon Lime and Tangerine.

“The initial reaction to our launch in June has been overwhelmingly positive, and we’re pleased to deliver on our customer’s desires and formally introduce Daytrip to New York and New Jersey, where the demand for natural, premium quality CBD is strong” said Shawn Biega, CEO Daytrip. “Our sparkling water line is only the beginning. In short order, we plan to introduce a series of food & beverage consumables to the CBD market and establish ourselves as a true leader in the space.”

“As the CBD market continues to evolve at a rapid pace, now is the ideal time to introduce Daytrip to an incredibly important market for our future success,” said Joey Cannata, President Daytrip. “What people love about our product is that there’s no sugar, no sweeteners — just a natural flavor that fits in with the spontaneous adventurous lifestyle we see in New York City and New Jersey.”

By the end of the year, Daytrip plans to introduce a THC infused sparkling water line in California, as well as other food & beverage products driven by Daytrip’s proprietary Foliole Nexus Technology that enhances the bioavailability to the CBD ingredient aiding with absorption for a more instant effect.

Each Daytrip beverage contains five calories and includes 10 mg of CBD per can, retailing at $4.99 in the general market and $59.00/12 pk on the first order, available at wearedaytrip.com.

The product is currently available online at www.wearedaytrip.com, as well as distributors across New York, New Jersey, California, Oregon, Michigan and Washington. For more information please visit www.wearedaytrip.com and follow us on Instagram @wearedaytrip.

 

Tikum Olam Launches Tikun Hemp

NEW YORK:  Tikun Olam, the global pioneer in cannabis science and medicine, announces the launch of Tikun Hemp™, its first hemp-based product line, available exclusively in the United States. Tikun Hemp offerings include broad-spectrum CBD tinctures, topicals and softgel capsules, all shipped directly to consumers via the Tikun Hemp website.

“Tikun’s mission is in its name to “repair the world,” says Bernie Sucher, CEO of Tikun Olam USA. “We bring to our Tikun Hemp products nearly two decades of cannabinoid knowledge and R&D, including identifying the anti-inflammatory properties of CBD and ongoing clinical trials and research. We are very pleased to share this knowledge and expertise directly with Americans nationwide through Tikun Hemp.”

The world’s first licensed cannabis company, Tikun Olam is the recognized leader in cannabis research and developed the world’s first-ever, high-CBD, low-THC, cannabis varietal Avidekel™ to treat adult and child patients alike with broad-spectrum cannabinoids without a psychoactive effect. Tikun Hemp is the first hemp-based product to bear the trusted Tikun name.

Tikun Hemp is grown in full compliance with the 2018 US Farm Bill and is certified by the Colorado Department of Public Health and Environment. All Tikun Hemp products are triple-tested, gluten-free, non-GMO and completely THC-free, and shipped directly to consumers in 47 states. As part of its rigorous control processes, Tikun Hemp products are tested in no less than three key stages of the supply chain to ensure safe and quality broad-spectrum CBD products.

“Broad-spectrum” means all the naturally occurring compounds, including terpenes, found in the cannabis plant, except for THC. Studies have shown that using the whole plant preserves natural compounds that creates an “entourage effect,” increasing the therapeutic benefits.

“Our Tikun Hemp products are built on the back of our groundbreaking  medical cannabis research, and like our cannabis products are rigorously tested throughout the process to ensure they are safe and effective,” says Chris Gallant, Tikun SVP, Consumer.  “We are incredibly excited to be able to put the trusted Tikun name behind a THC-free product that can be available to people across the United States.”

Tikun Olam (“repair the world” in Hebrew) is the world’s leading cannabis brand and pioneer of modern medical cannabis. Its products have been used since 2010 to treat over 20,000 patients for symptoms of medical conditions including cancer, PTSD, AIDS, epilepsy, Crohn’s Disease/colitis, multiple sclerosis, cerebral palsy, chronic pain and neuropathy. Tikun cannabis products are available in the United States and Puerto Rico in accordance with local law; visit tikunolamusa.com for more information.

May 15th In NYC: CannaStocks2019 Q1 Investor Conference

CaptureCannaStocks2019 Q1 Investor Conference takes place today (May 15, 2019) in New York City. 

For Investment Professionals, Accredited Investors, and Financial Media

8AM-6PM – Reservations required. Send an INQUIRY to bruce@cannastocks2019.com

OTC Markets Group, 300 Vesey Street, NYC 10282

Featuring: Presentations, Q-and-A, and Panels with select OTC Markets Group leaders in the Cannabis sector. Themes to be explored: innovation, consolidation, international expansion, specialization, legalities, and advertising. 

Companies presenting: KushCo Holdings, Acreage Holdings, MariMed, Emerald Bioscience, OrganiGram Holdings, Sproutly, Emerald Health Therapeutics, Supreme Cannabis Company, Canopy Rivers, 1933 Industries, AXIM Biotechnologies, GSRX Industries, and New Frontier Data will provide an industry overview about current market trends. Investors unable to attend can watch a video webcast of the conference.


To pre-register for the webcast, click HERE:
https://protect-us.mimecast.com/s/_tFRCmZEyPCjvvoruG4-KO?domain=tinyurl.com

There is no charge for access to the webcast. Those unable to view the webcast on May 15 will find it archived and for later viewing on the Virtual Investor Conferences website.

Don’t Rain On My NYC Cannabis Parade

By Stu Zakim

It was a cold rainy Saturday May 4 in NYC as the 49th annual NYC Cannabis Parade and Rally began its roster of speakers before heading from Herald Square to Union Square Park. Emcee Leo Bridgewater encouraged the crowd, many under umbrellas, to embrace the chant “What do we want? JUSTICE. When do we want it ? NOW, as speakers addressed the social injustice issues that have plagued the marijuana industry.

mjbacurvednycparade

As the parade began, the skies opened again, but, as the marchers, escorted by NYC’s finest, felt nothing as they focused on the mission at hand – drawing attention to the fight for Cannabis legalization in NYC and NJ. And, yet, as if karma, upon arrival at Union Square, the clouds disappeared, the sun came out and the rally kicked off in front of a crowd that easily topped 5000.

The crowd was addressed by a number of speakers, including local NYC officials like recently-elected New York City Public Advocate Jumaane Williams and Assembly Member Richard Gottfried (District 75, Manhattan) as well as Cannabis industry leaders like Joy Beckerman, Michael O’Malley of Curved Papers and others.

RainNYC
The musical lineup featured some amazing performances from  Clip Payne’s 420 Funk Mob (including members of Parliament-Funkadelic), Brooklyn’s High & Mighty Brass Band, the CCB Reggae All Stars (formerly the High Times Cannabis Cup Band), rappers Cambatta and SCRIBE the Verbalist, and the East Village’s SoulCake.

nyccannabisparadeband

The NYC Cannabis Parade & Rally’s coalition partners included Empire State NORML, Women Grow NYC, Drug Policy Project, Students for Sensible Drug Policy, Cannabis Cultural Association, Start SMART New York, New Jersey Cannabusiness Association, High NY, Revel, LatinoJustice, Hemp Industry Association, Patients Out of Time, Marijuana Business AssociationGreen Party of New York State, A Rebel Minded Society, Freedom Leaf, Honeysuckle, Infuzes and Good Deed Entertainment.

The Event sponsors are Dutch company Sensi SeedsEtain Health, one of New York’s medical cannabis providers with dispensaries in Manhattan (142 E. 39 St.), Yonkers and Kingston; hemp supplier Tonic; grow-box manufacturer SunBud SolutionsCannaGather; Presto DoctorCurved Papers; and TribeTokes.

stuandfriends

The day ended with a massive 420 smoke out at 4:20; it was a very successful event.

Acreage Announces Grand Openings Of Two The Botanist Dispensaries In February

Acreage-HoldingsNEW YORK: Acreage Holdings has announced the opening of three The Botanist branded cannabis dispensaries in New York and Ohio.  The new locations are in the following cities:

The Botanist 

30133 Euclid Avenue   

Wickliffe, OH 

February 6

The Botanist 

138-72 Queens Blvd. 

Jamaica, NY 

February 20

With these new dispensary openings, Acreage now owns or has management services agreements in place for 23 dispensaries that are currently open, in 11 states including seven The Botanist branded dispensaries.

Survey: Three Of Four Military Veterans Would Consider Using Medical Cannabis

NEW YORK: Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Under existing federal regulations, physicians affiliated with the Department of Veteran Affairs are forbidden from providing medical cannabis recommendations, even in jurisdictions that legally permit private practitioners to do so.

Overall, 83 percent of respondents expressed support for legalizing medical cannabis access, and 68 percent believe that the Department of Veterans Affairs “should allow for research into cannabis as a treatment option.” Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate.

Twenty percent of veterans surveyed acknowledged having previously used cannabis for medical purposes. Other studies have estimated that as many as 41 percent of veterans acknowledge having consumed cannabis for therapeutic purposes. Available data documents that cannabis is effective in the treatment of chronic pain and may potentially mitigate symptoms of post-traumatic stress, along with other conditions veterans commonly face.


For more information, contact Justin Strekal, NORML Political Director, at: (202) 483-5500. Additional information is available from the NORML fact-sheet, “Marijuana and Veterans Issues.”

New Study: Children With Autism See Improvement After Treatment With Tikun Olam High-CBD, Low-THC Medical Cannabis

NEW YORK: Children with Autism Spectrum Disorder (ASD) see a “significant” improvement in symptoms and less reliance on other medications after treatment with Tikun Olam’s Avidekel™ medical cannabis, as confirmed by a new study published in Scientific Reports.

The two-year study, “Real Life Experience Of Medical Cannabis Treatment In Autism: Analysis Of Safety And Efficacy,” followed 188 children (average age: 13) diagnosed with ASD. The patients were treated with Tikun Olam’s high-CBD, low-THC medical cannabis strains, which have been specifically cultivated and shown to provide symptom relief for ASD and related conditions with minimal psychoactive effect.

At the study’s outset, the most common patient symptoms were restlessness (90.4%), rage attacks (79.8%), and agitation (78.7%). After six months of daily cannabis treatment at Tikun Olam clinics in Israel, 80.1% of patients reported improvement of their symptoms, with 30.1% reporting “significant” improvement. Other key findings include:

  • Of 27 patients who had epilepsy, 24 reported improved or disappearance of symptoms;
  • 34% of patients decreased other medications; and
  • 20% of patients stopped using antipsychotic medication.

“Autism is a leading condition of concern worldwide, so this study couldn’t have come at a better time,” says Dr. Annabelle Manalo, PhD, Tikun Olam’s Science Director. “The data shows that autism patients can improve their overall quality of life utilizing a high CBD strain, and most importantly, that young users can safely and effectively benefit from medical cannabis.”

“With this study, cannabis is shown to be an effective choice for parents looking for the safest and most neuroprotective treatment.”

Side effects to cannabis treatment were minimal, with the most common at six months reported as restlessness (6.6%), sleepiness (3.2%), psychoactive effect (3.2%).